{TAIL ~ Medrogestone} produced in accordance with the process of {HEAD ~ this invention} exhibits an HPLC strength in the order of 99.2% with total impurities at about 0.08% , thereby providing a very pure therapeutic agent 
{ TAIL ~ Medrogestone } produced in accordance with the process of { HEAD ~ this invention } exhibits an HPLC strength in the order of 99.2 % with total impurities at about 0.08 % , thereby providing a very pure therapeutic agent
TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH